Evolus, Inc.
For the period ended Nov 4, 2026. Filed Nov 4, 2026.
View on SEC.govAbout this filing
A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.
Nov 4, 2026 · Filed Nov 4, 2026
Use the contents to explore the available documents and sections.
EOLS$6.81+0.1%Stored close · as of Nov 6, 2026
Contents
EX-99.1 · Adjusted EBITDA and Adjusted EBITDA Margin
Adjusted EBITDA and Adjusted EBITDA Margin
| Three Months Ended September 30, | Nine Months Ended September 30, | |||
|---|---|---|---|---|
| 2026 | 2025 | 2026 | 2025 | |
| GAAP net loss | $(12,516) | $(15,737) | $(31,242) | $(51,771) |
| Adjustments: | ||||
| Income tax expense | 285 | 167 | 387 | 292 |
| Interest income and expense | 3,951 | 3,615 | 11,517 | 14,048 |
| Depreciation and amortization | 1,577 | 1,143 | 4,644 | 2,899 |
| Amortization of distribution right intangible assets | 807 | 807 | 2,422 | 2,352 |
| Restructuring costs | — | 1,443 | — | 1,443 |
| Revaluation of contingent royalty obligation | 1,595 | (107) | 2,831 | (1,870) |
| Stock-based compensation: | ||||
| Included in selling, general and administrative | 5,291 | 4,963 | 15,267 | 15,058 |
| Included in research and development | 312 | 172 | 1,074 | 493 |
| Other income (expense), net | (148) | 455 | (481) | 549 |
| Adjusted EBITDA | $1,154 | $(3,079) | $6,419 | $(16,507) |
| Adjusted EBITDA margin | 1.5% | (4.5)% | 2.7% | (8.0)% |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.